Management

Kim Arvid Nielsen

Kim Arvid Nielsen

CEO

Kim Arvid Nielsen is a certified medical doctor from University of Copenhagen and he holds an E*MBA from SIMI. He has for the past 25 years been working in the pharma and biotech industry. First in companies like Pharmacia, Merck-Serono, Ferrosan and Bayer as Country Manager, Vice President and Head of Marketing and in the past 15 years in Danish and international biotech start-up companies like Pharmion, Basilea and Serendex as CEO.

As CEO for Serendex Kim Arvid Nielsen was responsible for the company’s IPO, subsequent delisting and successful merger with the US-based biotech company Savara Inc.

Kim Arvid Nielsen has been a member of the Board of Directors at several biotech companies.

Finn Eggert Sørensen

Finn Eggert Sørensen

CBO

Finn Eggert Sørensen is an experienced business developer and he has been working in the pharmaceutical industry for more than 35 years. He has held several management and senior management positions in Business Development (BD, Licensing, Patents, Legal and Competitive Intelligence), R&D and Project Management.

Finn Eggert Sørensen was for 15 years the EVP and CBO of NeuroSearch and he has also been serving Nordisk Gentofte, Nycomed Pharma, Contera Pharma and Serendex. He has a long track record of deal-making from distribution agreements to broad strategic alliances and M&A covering the full process from pitching the opportunity to closing the deal.

Finn Eggert Sørensen has been the chairman of the board or a board member at ZGene, Neurokey, Proteotarget and HeadExplorer and he holds a M. Sc. in Pharmacy from the University of Copenhagen.

Alexei Kirkin

Alexei Kirkin

CSO

Dr. Alexei Kirkin originally developed the ALECSAT technology and is today responsible for all research activities at CytoVac A/S. Dr. Kirkin is also managing the basic scientific immunology and cell biology research activities at the Danish Cancer Society, that are supported by CytoVac. Dr. Kirkin has published many scientific articles and patents, and has extensive experience in both academic basic research and more commercial clinical research, from employment in Danish and international research centers and companies.